The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunityстатья из журнала
Аннотация: Highlights•Mutation of OTULIN causes OTULIN-related autoinflammatory syndrome (ORAS) in humans•Anti-TNF treatment reverses inflammation in ORAS patient and OTULIN-deficient mice•OTULIN deficiency deregulates M1-polyUb signaling and causes sterile inflammation•Loss of OTULIN has cell-type-specific effects on LUBAC abundance and signalingSummaryMethionine-1 (M1)-linked ubiquitin chains regulate the activity of NF-κB, immune homeostasis, and responses to infection. The importance of negative regulators of M1-linked chains in vivo remains poorly understood. Here, we show that the M1-specific deubiquitinase OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice. A homozygous hypomorphic mutation in human OTULIN causes a potentially fatal autoinflammatory condition termed OTULIN-related autoinflammatory syndrome (ORAS). Four independent OTULIN mouse models reveal that OTULIN deficiency in immune cells results in cell-type-specific effects, ranging from over-production of inflammatory cytokines and autoimmunity due to accumulation of M1-linked polyubiquitin and spontaneous NF-κB activation in myeloid cells to downregulation of M1-polyubiquitin signaling by degradation of LUBAC in B and T cells. Remarkably, treatment with anti-TNF neutralizing antibodies ameliorates inflammation in ORAS patients and rescues mouse phenotypes. Hence, OTULIN is critical for restraining life-threatening spontaneous inflammation and maintaining immune homeostasis.Graphical abstract
Год издания: 2016
Авторы: Rune Busk Damgaard, Jennifer A. Walker, Paola Marco‐Casanova, Neil V. Morgan, Hannah Titheradge, P.R. Elliott, Duncan McHale, Eamonn R. Maher, Andrew N. J. McKenzie, David Komander
Издательство: Cell Press
Источник: Cell
Ключевые слова: Immune Cell Function and Interaction, Inflammasome and immune disorders, Autoimmune and Inflammatory Disorders Research
Другие ссылки: Cell (HTML)
University of Birmingham Research Portal (University of Birmingham) (PDF)
University of Birmingham Research Portal (University of Birmingham) (HTML)
Apollo (University of Cambridge) (PDF)
Apollo (University of Cambridge) (HTML)
University of Birmingham Research Portal (University of Birmingham) (HTML)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
PubMed (HTML)
University of Birmingham Research Portal (University of Birmingham) (PDF)
University of Birmingham Research Portal (University of Birmingham) (HTML)
Apollo (University of Cambridge) (PDF)
Apollo (University of Cambridge) (HTML)
University of Birmingham Research Portal (University of Birmingham) (HTML)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
PubMed (HTML)
Открытый доступ: hybrid
Том: 166
Выпуск: 5
Страницы: 1215–1230.e20